Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1984 1
2000 1
2001 4
2003 3
2004 2
2006 1
2008 3
2009 3
2010 3
2011 3
2012 3
2013 2
2014 3
2015 3
2016 3
2017 2
2018 4
2019 3
2020 4
2021 10
2022 8
2023 2
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Calleri A, Saracco M, Pittaluga F, Cavallo R, Romagnoli R, Martini S. Calleri A, et al. Liver Transpl. 2022 Mar;28(3):515-516. doi: 10.1002/lt.26328. Epub 2021 Nov 8. Liver Transpl. 2022. PMID: 34619020 Free PMC article. No abstract available.
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial.
Tedeschi A, Frustaci AM, Condoluci A, Coscia M, Chiarle R, Zinzani PL, Motta M, Gaidano G, Quaresmini G, Scarfò L, Catania G, Deodato M, Jones R, Tabanelli V, Griggio V, Stüssi G, Calleri A, Pini K, Cairoli R, Zenz T, Signori A, Zucca E, Rossi D, Montillo M. Tedeschi A, et al. Lancet Oncol. 2024 Oct;25(10):1298-1309. doi: 10.1016/S1470-2045(24)00396-6. Epub 2024 Sep 10. Lancet Oncol. 2024. PMID: 39270702 Clinical Trial.
Telomere Disorders and the Liver.
Calleri A, Simonetto DA. Calleri A, et al. Clin Liver Dis. 2025 Aug;29(3):385-405. doi: 10.1016/j.cld.2025.03.001. Epub 2025 May 12. Clin Liver Dis. 2025. PMID: 40670029 Review.
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma.
Derenzini E, Mazzara S, Melle F, Motta G, Fabbri M, Bruna R, Agostinelli C, Cesano A, Corsini CA, Chen N, Righi S, Sabattini E, Chiappella A, Calleri A, Fiori S, Tabanelli V, Cabras A, Pruneri G, Vitolo U, Gianni AM, Rambaldi A, Corradini P, Zinzani PL, Tarella C, Pileri S. Derenzini E, et al. Haematologica. 2021 Sep 1;106(9):2405-2416. doi: 10.3324/haematol.2019.236455. Haematologica. 2021. PMID: 32817282 Free PMC article.
Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis.
Merlo MEB, Mallardo M, Luzi L, De Conti G, Caprioli C, Hillje R, Faretta M, Restelli C, Polazzi A, Tabanelli V, Calleri A, Pileri S, Pelicci PG, Colombo E. Merlo MEB, et al. Haematologica. 2025 Sep 1;110(9):2009-2023. doi: 10.3324/haematol.2024.286577. Epub 2025 Mar 13. Haematologica. 2025. PMID: 40079083 Free PMC article.
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.
Rossi A, Mazzara S, Salemi D, Zanetti S, Sapienza MR, Orecchioni S, Talarico G, Falvo P, Davini A, Ceccarelli C, Motta G, Melle F, Tabanelli V, Agostinelli C, Trerè D, Penzo M, Corsini C, Baiardi E, Calleri A, Vitolo U, Bertolini F, Zinzani PL, Chiarle R, Tarella C, Pileri S, Derenzini E. Rossi A, et al. iScience. 2025 Apr 2;28(5):112333. doi: 10.1016/j.isci.2025.112333. eCollection 2025 May 16. iScience. 2025. PMID: 40276769 Free PMC article.
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.
Tabanelli V, Melle F, Motta G, Mazzara S, Fabbri M, Agostinelli C, Calleri A, Del Corvo M, Fiori S, Lorenzini D, Cesano A, Chiappella A, Vitolo U, Derenzini E, Griffin GK, Rodig SJ, Vanazzi A, Sabattini E, Tarella C, Sapienza MR, Pileri SA. Tabanelli V, et al. Blood Adv. 2022 Aug 9;6(15):4634-4644. doi: 10.1182/bloodadvances.2022007046. Blood Adv. 2022. PMID: 35767735 Free PMC article.
72 results